Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;20(3):221-231.

Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion

Mine Gayaf  1 , Ceyda Anar  1 , Mustafa Canbaz  1 , Dursun Tatar  1 , Filiz Güldaval  1
Affiliations

Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion

Mine Gayaf et al. Tanaffos. 2021 Mar.

Abstract

Background: The aim of our study is to determine the clinical availability accessibility of cancer ratio and cancer ratio plus formulations, previously validated and reported to have clinical value in distinguishing malignant pleural effusion from tuberculosis pleurisy and parapneumonic effusion.

Materials and methods: Retrospective study of patients hospitalized with Malignant Pleural Effusion (MPE), tuberculosis (TPE) and pararapneumonic effusion (PPE) between 2009 and 2018.

Results: Totally 232 patients, 101(43.5 %) having MPE, 86 (37.1 %) having PPE and 45 (19.4 %) TPE were examined. When compared with each other, "serum LDH / PS Lymphocyte %", "Cancer ratıo" and "Cancer ratıo plus" values were statistically different between the groups (p = 0.021, p <0.001 and p = 0.015, respectively). In multivariate logistic regression analysis, cancer ratio, serum LDH: pleural fluid lymphocyte count ratio was in positive correlation with MPE. The sensitivity and specificity of "cancer ratio", "cancer ratio plus" and "ratio of serum LDH: pleural fluid lymphocyte count" were 84.2 % (95% CI 75.6- 90.7) and 52.7 (95% CI 43.8- 61.5), and 82.2 % (95% CI 73.3- 89.1) and 45.8 (95%CI 37.1- 54.7), 53.5% (95% CI 43.3- 63.5) and 67.2% (95% CI 0.68-0.94) at the cut-off level of >14.25, >28.7, and >636, respectively. When considering only MPE and TPE patients, the specificity of cancer ratıo and cancer ratıo plus increased.

Conclusion: The cancer ratio plus rate (the ratio of "cancer ratio"formulation to the percentage of differential pleural lymphocyte count) was almost the same as the cancer ratio in separating the malignant pleural effusion from the TPE and PPE, while it has better specificity only in differentiating malignant effusions from tuberculosis effusions.

Keywords: Cancer ratio; Cancer ratio plus; Malignant; Parapneumonic effusion; Pleural Effusion; Tuberculosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
ROC analysis for Cancer Ratio (Serum LDH: Pleural Fluid ADA) In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion and Parapneumonic Effusion B) ROC analysis for Cancer Ratio Plus (Cancer Ratio: Pleural Fluid Lymphocyte Count) In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion and Parapneumonic Effusion C) ROC analysis for Serum LDH: Pleural Lymphocyte Count Ratio In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion and parapneumonic Effusion
Figure 2.
Figure 2.
A) ROC analysis for Cancer Ratio (Serum LDH: Pleural Fluid ADA) In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion B) ROC analysis for Cancer Ratio Plus (Cancer Ratio: Pleural Fluid Lymphocyte Count) In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion C) ROC analysis for Serum LDH: Pleural Lymphocyte Count Ratio In Distinguishing Malignant Pleural Effusion From Tuberculosis Effusion
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Porcel JM, Azzopardi M, Koegelenberg CF, Maldonado F, Rahman NM, Lee YC. The diagnosis of pleural effusions. Expert Rev Respir Med 2015;9(6):801–15. - PubMed
    1. Wang XJ, Yang Y, Wang Z, Xu LL, Wu YB, Zhang J, et al. Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions. Respiration 2015;90(3):251–5. - PubMed
    1. Assawasaksakul T, Boonsarngsuk V, Incharoen P. A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion. J Thorac Dis 2017;9(9):3161–7. - PMC - PubMed
    1. Verma A, Abisheganaden J, Light RW. Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio). Lung 2016;194(1):147–53. - PMC - PubMed
    1. Lott JA, Nemensanszky E. Lactate dehydrogenase. In: Lott JA, Wolf PL. (eds) Clinical enzymology, a case oriented approach. Year Book Medical, New York, 1987; pp 213–244.

LinkOut - more resources